23 Degree, Timing and Factors Observed in COVID-19 Post-Vaccination Humoral Antibody Development

por Pepe, P.E., Antevy, P.M., Rosenberg, L., Cabral, M., Scheppke, K.A., Jui, J., Marty, A.M.
Publicado 2021

60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination

por Pepe, P.E., Antevy, P.M., Marty, A.M., Jui, J., Cabral, M., Rosenberg, L., Scheppke, K.A.
Publicado 2021